Form 4 for BLND Blend Labs, Inc.
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-23 · accession 0001209191-22-013181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-25 | 2022-02-23 | BLND | Mayopoulos Timothy J | Pres, Dir | A - Grant | $0.00 | +335.9K | 693.4K | +94% | $0 |
| D | 2022-02-25 | 2022-02-23 | BLND | Mayopoulos Timothy J | Pres, Dir | A - Grant | $0.00 | +113.7K | 113.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-23 | A | A | 335,851 | $0.00 | 693,369 | D | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal quarterly increments over a one year period, subject to the Reporting Person continuing to be a Service Provider through each such date. |
| 2 | Derivative | Stock Option (right to buy) | 2022-02-23 | A | A | 113,658 | $0.00 | 113,658 | D | $8.45 · — to 2032-02-22 | 113,658 Class A Common Stock | (F2) The shares subject to this option will fully vest on December 31, 2022. |